TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.

Megan L Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.